(Q36019417)

11 August 2017

1 reference

title

Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities (English)

1 reference

11 August 2017

main subject

Guillain–Barré syndrome

0 references

1 reference

Toshio Ariga

1

1 reference

11 August 2017

Robert K Yu

series ordinal

2

1 reference

11 August 2017

publication date

1 April 2005

1 reference

Journal of Neuroscience Research

11 August 2017

published in

1 reference

11 August 2017

volume

80

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

1-17

1 reference

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients

11 August 2017

cites work

1 reference

The Guillain-Barré syndrome: a true case of molecular mimicry

21 January 2018

1 reference

Identification of Gal(beta 1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve.

21 January 2018

1 reference

Acute conduction block in vitro following exposure to antiganglioside sera.

21 January 2018

1 reference

Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders

21 January 2018

1 reference

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

21 January 2018

1 reference

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

21 January 2018

1 reference

Procedure for isolation of gangliosides in high yield and purity: simultaneous isolation of neutral glycosphingolipids

21 January 2018

1 reference

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

21 January 2018

1 reference

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

21 January 2018

1 reference

Ganglio-N-tetraosylceramide (GA1) of bovine and human brain. Molecular characterization and presence in myelin.

21 January 2018

1 reference

Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope

21 January 2018

1 reference

Localization of major gangliosides in the PNS: implications for immune neuropathies

21 January 2018

1 reference

Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis.

21 January 2018

1 reference

Human autoimmune neuropathies

21 January 2018

1 reference

Controlled trial prednisolone in acute polyneuropathy

21 January 2018

1 reference

Induction of conduction block by Campylobacter jejuni lipopolysaccharides and focal neural insult.

21 January 2018

1 reference

Antibodies to sulfated glycolipids in Guillain-Barré syndrome

21 January 2018

1 reference

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding

21 January 2018

1 reference

Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review

21 January 2018

1 reference

Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a

21 January 2018

1 reference

Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].

21 January 2018

1 reference

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

21 January 2018

1 reference

Guillain-Barré syndrome associated with IgG anti-GM1b antibody subsequent to Mycoplasma pneumoniae infection

21 January 2018

1 reference

Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?

21 January 2018

1 reference

Nerve conduction studies in selected peripheral nerve disorders

21 January 2018

1 reference

Ganglio-N-tetraosylceramide (asialo GM1), an antigen common to the brain and immune system: its localization in myelin

21 January 2018

1 reference

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

21 January 2018

1 reference

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

21 January 2018

1 reference

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

21 January 2018

1 reference

The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis

21 January 2018

1 reference

Preliminary studies on sensitization of Lewis rats with sulfated glucuronyl paragloboside

21 January 2018

1 reference

Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen

21 January 2018

1 reference

Sialosyl-galactose: a common denominator of Guillain-Barré and related disorders?

21 January 2018

1 reference

Effect of amyotrophic lateral sclerosis serum on calcium channels related to spontaneous acetylcholine release

21 January 2018

1 reference

Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.

21 January 2018

1 reference

Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides

21 January 2018

1 reference

Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection

21 January 2018

1 reference

Multifocal motor neuropathy.

21 January 2018

1 reference

Anti-GQ1b IgG antibody syndrome: clinical and immunological range

21 January 2018

1 reference

IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.

21 January 2018

1 reference

Use of peptide ligands to analyze the fine specificity of antibodies against asialo GM1.

21 January 2018

1 reference

Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells

21 January 2018

1 reference

Molecular specializations at nodes and paranodes in peripheral nerve

21 January 2018

1 reference

The distribution of ganglioside-like moieties in peripheral nerves

21 January 2018

1 reference

Identification of a peptide mimic of the L2/HNK-1 carbohydrate epitope

21 January 2018

1 reference

Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons

21 January 2018

1 reference

Cholinergic neuron-specific ganglioside GQ1b alpha a possible target molecule for serum IgM antibodies in some patients with sensory ataxia.

21 January 2018

1 reference

Effect of rabbit anti-asialo-GM1 (GA1) polyclonal antibodies on neuromuscular transmission and acetylcholine-induced action potentials: neurophysiological and immunohistochemical studies

21 January 2018

1 reference

Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission

21 January 2018

1 reference

A small sodium channel blocking factor in the cerebrospinal fluid is preferentially found in Guillain-Barré syndrome: a combined cell physiological and HPLC study.

21 January 2018

1 reference

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

21 January 2018

1 reference

Gangliosides and bacterial toxins in Guillain-Barré syndrome

21 January 2018

1 reference

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

Autoimmune mechanisms in peripheral neuropathies

21 January 2018

1 reference

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

21 January 2018

1 reference

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

21 January 2018

1 reference

Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha

21 January 2018

1 reference

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

21 January 2018

1 reference

Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera

21 January 2018

1 reference

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

The clinical correlates of high-titer IgG anti-GM1 antibodies

21 January 2018

1 reference

Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.20395

1 reference

11 August 2017

1 reference